Bracco Imaging Expands Portfolio of Personalized Diagnostics With the Acquisition of Blue Earth Diagnostics
MILAN, June 27, 2019 -- (Healthcare Sales & Marketing Network) -- Bracco Imaging S.p.A., a global leader in diagnostic imaging, today announced that it had signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular imaging company based ... Diagnostics, Mergers & Acquisitions Bracco Imaging, Blue Earth Diagnostics, molecular imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 27, 2019 Category: Pharmaceuticals Source Type: news

Trust merger set back by NHS Improvement concerns
Plans to merge two mental health trusts in the West Midlands have suffered a set back after proposals were queried by NHS Improvement, HSJ can reveal (Source: HSJ)
Source: HSJ - June 27, 2019 Category: UK Health Source Type: news

Celebrating 40 Years: 2000s Medtech Milestones
Click here to check out the next decade, 2010s Medtech Milestones Click here to check out the previous decade, 1990s Medtech Milestones Or, for further reading on the milestones mentioned above, check out these links: Forging New Regulatory Pathways at FDA It's a Small World, After All Blazing New Paths for Product Introductions Global Market Trends in Surgical Navigation For J&J, Drug-Coated Stents Were an Albatross Learning from the Guidant Acquisition Anne Wojcicki: 10 People Who Changed the Medtech Industry​​​​​â€&#...
Source: MDDI - June 26, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

UnitedHealth buys PatientsLikeMe, the startup forced by Trump administration to find a buyer
UnitedHealth Group Inc. has acquired PatientsLikeMe, a health-technology startup forced by the Trump administration to seek a buyer because its majority owner is Chinese, CNBC reports. PatientsLikeMe, founded in 2004, provides a social network on which patients can connect to people with similar health conditions. According to an email sent to customers, the Cambridge, Mass.-based startup was folded into UnitedHealth's research and development group last Wednesday. Terms of the acquisition… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 25, 2019 Category: Health Management Authors: Alex Wittenberg Source Type: news

AbbVie to buy Botox maker Allergan for $63 billion
The acquisition aims to diversify AbbVie beyond its top-selling drug Humira, which will soon lose patent protection (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 25, 2019 Category: Consumer Health News Source Type: news

AbbVie to Acquire Allergan in Transformative Move for Both Companies
Provides immediate scale and profitability to AbbVie's growth platform, excluding Humira, significantly expanding and diversifying its revenue base with new therapeutic areas, including Allergan's leading medical aesthetics business Enhances long-term R... Biopharmaceuticals, Mergers & Acquisitions AbbVie, Allergan (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 25, 2019 Category: Pharmaceuticals Source Type: news

Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal
The transaction would give AbbVie a potent source of popular treatments as it faces the loss of patent protection for its best-selling drug, Humira. (Source: NYT Health)
Source: NYT Health - June 25, 2019 Category: Consumer Health News Authors: Michael J. de la Merced Tags: Allergan Inc Mergers, Acquisitions and Divestitures Drugs (Pharmaceuticals) AbbVie Inc Botox (Drug) Source Type: news

Four CCGs looking at 1 million population merger
Four Surrey clinical commissioning groups are considering a merger to create a single organisation covering more than a million people. (Source: HSJ)
Source: HSJ - June 25, 2019 Category: UK Health Source Type: news

Acer Therapeutics Receives Complete Response Letter from U.S. FDA for use of Edsivo (celiprolol) in vEDS Patients
NEWTON, MA– June 25, 2019– Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - June 25, 2019 Category: Drugs & Pharmacology Source Type: news

Phreesia, a 14-year digital health stalwart in the patient intake space, files for IPO
The New York company's S-1 reveals a recent profitable turn and a quiet 2018 acquisition. (Source: mobihealthnews)
Source: mobihealthnews - June 24, 2019 Category: Information Technology Source Type: news

Centene And WellCare Shareholders OK Merger With Little Resistance
Shareholders overwhelmingly approved Centene's purchase of WellCare Health Plans. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 24, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

BMS to divest Celgene drug to speed delayed deal
Bristol-Myers Squibb said it is planning to sell Otezla, Celgene's treatment for certain types of psoriasis and psoriatic arthritis, in an effort to address Federal Trade Commission concerns about its pending merger with Celgene. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - June 24, 2019 Category: Pharmaceuticals Source Type: news

BMS to divest Celgene drugs to speed delayed deal
Bristol-Myers Squibb said it is planning to sell Otezla, Celgene's treatment for certain types of psoriasis and psoriatic arthritis, in an effort to address Federal Trade Commission concerns about its pending merger with Celgene. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - June 24, 2019 Category: Pharmaceuticals Source Type: news

Undaunted By FTC, UnitedHealth And Optum Ready For More Deals
UnitedHealth Group ’s Optum unit may be amid a spending spree following its much anticipated acquisition of DaVita Medical Group. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 24, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

Bristol-Myers Squibb provides update on pending merger with Celgene
Bristol-Myers Squibb Company (NYSE: BMY) today provided an update on the approval process and timeline for the Company’s pending merger with Celgene Corporation (NASDAQ: CELG). The Company remains actively engaged in discussions with the U.S. Federal Trade Commission ("FTC") on the FTC's continued review of the proposed transaction. (Source: World Pharma News)
Source: World Pharma News - June 24, 2019 Category: Pharmaceuticals Tags: Featured Bristol-Myers Squibb Business and Industry Source Type: news

Mathematics ties media coverage of gun control to upticks in gun purchases
(NYU Tandon School of Engineering) For the first time, researchers have shown a causal link between print news media coverage of US gun control policy in the wake of mass shooting events and increases in firearm acquisition, particularly in states with the least restrictive gun laws. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 24, 2019 Category: International Medicine & Public Health Source Type: news

Healthcare company's first two acquisitions helped revenue surge to $122 million in 2018
Three-year revenue growth (2016-18): 210.7% 2018 revenue: $122 million 2017 revenue: $65 million 2016 revenue: $39.3 million This Dallas-based health care company provides management and application services and automation tools to health care providers, payers and service providers and has grown revenue over 200 percent in three years. 2 018 brought its first two acquisitions — Pacific BPO and Mediserve — which helped revenue surge to $122 million last year. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 21, 2019 Category: American Health Authors: Rob Schneider Source Type: news

Hologic Sets M & amp;A Sights on SuperSonic Imagine in $85M Deal
In an attempt to boost its imaging offerings for breast health, Hologic has made a binding offer to acquire SuperSonic Imagine for $85 million. Aix-En-Provence, France-based Sonic Imagine develops cart-based ultrasound products. Hologic also would make available funds to repay SuperSonic Imagine’s net debt in an amount not to exceed $43 million, equating to a maximum enterprise value of $85 million. SuperSonic Imagine’s main shareholders, who together hold 10,841,409 shares or about 46% of the outstanding share capital of the company, have agreed to sell their shares to Hologic at the pr...
Source: MDDI - June 21, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Bound Tree Medical to Acquire EMS Business from Concordance Healthcare Solutions
Bound Tree Medical, LLC, announced that the company has signed a definitive agreement to acquire the EMS business from Concordance Healthcare Solutions, LLC. Bound Tree, one of the largest national distributors of medical equipment and supplies serving the EMS industry, will assume full operation of the Concordance EMS business under the Bound Tree brand name starting July 15, 2019. Concordance Healthcare Solutions is one of the largest independent national distributors of medical supplies and supply chain solutions. Since its merger in 2016, Concordance has continued to make strategic investments expanding their distribut...
Source: JEMS Operations - June 21, 2019 Category: Emergency Medicine Tags: Operations Press Releases Source Type: news

Diagnostic Imaging Centers adds new market with acquisition
Overland Park-based Diagnostic Imaging Centers PA has expanded beyond the metro area with its latest acquisition, announced Thursday. The company acquired St. Joseph-based Watson Imaging for an undisclosed amount, Diagnostic Imaging Centers said in a release. The deal, effective Aug. 1, will include the staff. The acquisition extends a move northward that Diagnostic Imaging Centers started in late 2017, when it acquired three r adiology locations from Northland Imaging, bringing its metro-area total… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 21, 2019 Category: Health Management Source Type: news

Diagnostic Imaging Centers adds new market with acquisition
Overland Park-based Diagnostic Imaging Centers PA has expanded beyond the metro area with its latest acquisition, announced Thursday. The company acquired St. Joseph-based Watson Imaging for an undisclosed amount, Diagnostic Imaging Centers said in a release. The deal, effective Aug. 1, will include the staff. The acquisition extends a move northward that Diagnostic Imaging Centers started in late 2017, when it acquired three r adiology locations from Northland Imaging, bringing its metro-area total… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 21, 2019 Category: Biotechnology Source Type: news

Cecil County's Union Hospital signs letter of intent to explore merger with Delaware health system
Christiana Care Health System signed a letter of intent Thursday to explore the possibility of Union Hospital in Cecil County and its affiliates joining the Delaware-based Christiana system. Financial terms of the proposed deal are being kept confidential. Under the terms of the letter of intent, the two health care organizations have entered a period of exclusive negotiation and due diligence — a process that is expected to take several months to complete. If a final affiliation a greement is… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 20, 2019 Category: Health Management Authors: John George Source Type: news

Cecil County's Union Hospital signs letter of intent to explore merger with Delaware health system
Christiana Care Health System signed a letter of intent Thursday to explore the possibility of Union Hospital in Cecil County and its affiliates joining the Delaware-based Christiana system. Financial terms of the proposed deal are being kept confidential. Under the terms of the letter of intent, the two health care organizations have entered a period of exclusive negotiation and due diligence — a process that is expected to take several months to complete. If a final affiliation a greement is… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 20, 2019 Category: Biotechnology Authors: John George Source Type: news

Large Financing Round Breathes New Life into Acutus ’ AcQMap
Acutus Medical has turned up the heat for its latest financing – raising $170 million in a Series D round. A breakdown of the financing shows that $100 million came from a Series D equity round and $70 million came from a credit facility. The Carlsbad, CA-based company said the Series D equity financing round includes new investors 8VC, Opaleye Management, Pura Vida Investments, among others. The round also included strong participation from existing investors including OrbiMed, Deerfield Management Company, Advent Venture Partners, Xeraya Capital and GE Ventures. The credit facility was provided by OrbiM...
Source: MDDI - June 20, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news

Even With Las Vegas Divestiture, Optum Gains Key New Markets
UnitedHealth Group ’s acquisition of DaVita Medical Group will bring the health insurer’s Optum provider business several key fast-growing new markets despite an FTC-ordered divestiture of Las Vegas medical providers. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 20, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

Minneapolis medical-marijuana company expands into Puerto Rico
Vireo Health International Inc., the parent company of Minnesota Medical Solutions and several other medical-marijuana ventures, has gained approval to grow and sell medical marijuana in Puerto Rico, the 11th market for the sprouting company. Minneapolis-based Vireo Health announced the news Thursday. The expansion follows the company's acquisition of a number of pre-approval licenses to grow and sell cannabis products at up to six dispensaries on the island country. The company has leased a… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 20, 2019 Category: Pharmaceuticals Authors: Alex Wittenberg Source Type: news

Practice mergers, super-partnerships and networks - understanding your options
General practices can no longer afford to take a go-it-alone approach if they hope to survive. As the NHS Long Term Plan makes clear, the welcome injection of new money for general practice is conditional on practices being prepared to work at scale. (Source: NHS Networks)
Source: NHS Networks - June 20, 2019 Category: UK Health Source Type: news

UnitedHealth completes $4 billion acquisition of DaVita physician group
UnitedHealth Group Inc. has completed its $4.3 billion acquisition of the physician group of DaVita Inc. after scrutiny from regulators stalled the purchase by more than a year, the company said Wednesday. News of the Minnetonka-based health insurer's intention to buy DaVita's physician group was first reported in December 2017. At the time, UnitedHealth expected to close the deal in 2018, but a regulatory process that dragged on longer than expected delayed the purchase, which was trimmed from… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 19, 2019 Category: Biotechnology Authors: Alex Wittenberg Source Type: news

UnitedHealth completes $4 billion acquisition of DaVita physician group
UnitedHealth Group Inc. has completed its $4.3 billion acquisition of the physician group of DaVita Inc. after scrutiny from regulators stalled the purchase by more than a year, the company said Wednesday. News of the Minnetonka-based health insurer's intention to buy DaVita's physician group was first reported in December 2017. At the time, UnitedHealth expected to close the deal in 2018, but a regulatory process that dragged on longer than expected delayed the purchase, which was trimmed from… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 19, 2019 Category: American Health Authors: Alex Wittenberg Source Type: news

UnitedHealth completes $4.3 billion acquisition of DaVita physician group
UnitedHealth Group Inc. has completed its $4.3 billion acquisition of the physician group of DaVita Inc. after scrutiny from regulators stalled the purchase by more than a year, the company said Wednesday. News of the Minnetonka-based health insurer's intention to buy DaVita's physician group was first reported in December 2017. At the time, UnitedHealth expected to close the deal in 2018, but a regulatory process that dragged on longer than expected delayed the purchase, which was trimmed from… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 19, 2019 Category: Biotechnology Authors: Alex Wittenberg Source Type: news

Multi-detector computed tomography in the diagnosis and characterization of adrenal gland traumatic injuries - Addeo G, Cozzi D, Danti G, Bertelli E, Ferrari R, Pradella S, Trinci M, Miele V.
Adrenal gland injuries after a blunt abdominal trauma are rare events and represent important indicators for severe trauma. Multidetector CT evolution with high volumetric resolution and fast acquisition with the use of multiplanar reformatted (MPR) visual... (Source: SafetyLit)
Source: SafetyLit - June 19, 2019 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

UnitedHealth Group Wins FTC Approval Of DaVita Deal On Divestiture Conditions
UnitedHealth Group's Optum has won Federal Trade Commission approval of its $4 billion acquisition of DaVita Medical Group after a settlement was reached over allegations of a monopoly in the Las Vegas market. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 19, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

U of M, Children's Minnesota weighed hospital merger, but talks fell apart
The state's two largest children's hospitals have called off a plan that would have combined University of Minnesota Masonic Children's Hospital and Children's Minnesota into a “new, independent pediatric care system." But the idea ran aground over disagreements about control. The Star Tribune has details, citing emails and documents the paper has reviewed. The talks apparently took place last year but were called off due to disagreements over finances, staffing and ot her issues. The hospitals… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 19, 2019 Category: American Health Authors: Mark Reilly Source Type: news

Atlanta-based cannabis chain Surterra's acquisition of Boston-based NETA gets OK
The Massachusetts cannabis company with dispensaries in Brookline and Northampton and a cultivation facility in Franklin received approval from Brookline ’s Board of Selectmen on Tuesday. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 19, 2019 Category: American Health Authors: Jessica Bartlett Source Type: news

Zoll Acquires TherOx for Undisclosed Sum
Fresh off receiving a PMA, TherOx is now in the process of being acquired by Zoll Medical, an Asahi Kasei Group Company.  Additional terms of the deal were not disclosed. Irvine, CA-based TherOX is focused on improving the treatment of acute myocardial infarction, and markets systems to deliver SuperSaturated Oxygen (SSO2) Therapy. The therapy has been demonstrated to reduce infarct size after primary coronary intervention (PCI) with stenting in patients with left anterior descending ST-elevation myocardial infarction. When a large ischemic area of muscle damage remains following AMI, the patient condition oft...
Source: MDDI - June 18, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

ANI Pharmaceuticals Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis Pharmaceuticals, Inc.
BAUDETTE, Minn., June 18, 2019 -- (Healthcare Sales & Marketing Network) -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has acquired a pipeline of seven development stage generic products from Coeptis Pharmaceuticals... Biopharmaceuticals, Generics, Acquisitions ANI Pharmaceuticals, Coeptis Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 18, 2019 Category: Pharmaceuticals Source Type: news

Varian closes acquisition of cancer treatment provider
Radiation therapy firm Varian Medical Systems has successfully acquired Cancer...Read more on AuntMinnie.comRelated Reading: Varian adds 2 interventional companies to roster Varian to acquire cancer treatment provider Varian completes ProBeam cyclotron install in Singapore Varian buys CyberHeart, wins Norwegian ProBeam contract Varian brings Bravos afterloader to Africa (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 18, 2019 Category: Radiology Source Type: news

Pfizer bolsters cancer pipeline with $10B acquisition
Pfizer has agreed to buy Array Biopharma in a $10.64 billion cash deal. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - June 17, 2019 Category: Pharmaceuticals Source Type: news

Pfizer acquires Array in 2nd major Boulder bioscience merger this month
The deal is valued at more than $11 billion. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 17, 2019 Category: Health Management Authors: Jensen Werley Source Type: news

Pfizer acquires Array in 2nd major Boulder bioscience merger this month
The deal is valued at more than $11 billion. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 17, 2019 Category: Biotechnology Authors: Jensen Werley Source Type: news

Merit Stays the Course with Brightwater Acquisition
Merit Medical Systems said it has acquired Brightwater Medical for a $35 million upfront payment and potential earn-out payments of up to $15 million based on receipt of CE mark approval and achievement of future sales targets. Brightwater's primary product is the ConvertX, which is a single device used to replace a series of devices and procedures used to treat severe obstructions of the ureter. The system is designed to be implanted once and converted from a nephroureteral catheter to a nephroureteral stent without requiring sedation or local anesthesia. The device is FDA cleared but does not yet have CE mark approval in...
Source: MDDI - June 17, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Where & #039;s Robotic-Assisted Surgery Headed?
Will Intuitive Surgical’s da Vinci system be dethroned as the industry leader? Can one robotic platform handle all surgeries? Will autonomous robots take over in surgery? These topics and more were tackled during MD&M East’s June 12 panel discussion, “Robotic Surgery - Visions of the Future.” Led by Shana Leonard, Informa Markets’s vice president of content, the panel featured Gianluca De Novi, PhD, CEO at XSurgical; Anthony Fernando, Chief Operating Officer & CTO at TransEnterix; and Dave Saunders, chief technology officer at...
Source: MDDI - June 17, 2019 Category: Medical Devices Authors: Daphne Allen Tags: Business Source Type: news

Invitae Takes a Deeper Dive into NIPS with New M & amp;A Target
Invitae’s latest acquisition is set to firmly entrench the genetics company in the non-invasive prenatal screening (NIPS). The San Francisco-based company said it signed a definitive agreement to acquire Singular Bio for $55 million. Singular Bio specializes in developing single molecule detection technology that enables lower costs and expanded use of high-quality, cell-free, nucleic acid analysis, initially for application in NIPS. The acquisition is expected to close in the coming weeks, subject to customary closing conditions. Invitae noted the transaction will be cash neutral at close and has already...
Source: MDDI - June 17, 2019 Category: Medical Devices Authors: Omar Ford Tags: IVD Source Type: news

CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy
ROCKVILLE, Md., June 17, 2019 -- (Healthcare Sales & Marketing Network) -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company that is focusing on developing and accelerating the launch of innovative therapeutics and pharmaceutical... Biopharmaceuticals, Oncology, Licensing, Acquisitions CASI Pharmaceuticals, Juventas Cell Therapy, T-cell therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 17, 2019 Category: Pharmaceuticals Source Type: news

Pfizer to Acquire Array BioPharma
Proposed acquisition strengthens Pfizer's innovative biopharmaceutical business and is expected to accelerate its growth trajectory particularly in the long term Opportunity to strengthen category leadership in Oncology with the addition of a breakthrou... Biopharmaceuticals, Mergers & Acquisitions Array BioPharma, Pfizer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 17, 2019 Category: Pharmaceuticals Source Type: news

Merck's Full Court Press On Oncology
Earlier this week, Merck entered into an agreement to acquire Tilos Therapeutics for up to $773 million. Such acquisitions demonstrate how heavily invested Merck is in immuno-oncology, an area in which it is currently well-positioned with the PD-1 inhibitor Keytruda. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 14, 2019 Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Source Type: news

Merck's Full Court Press On Oncology
Earlier this week, Merck entered into an agreement to acquire Tilos Therapeutics for up to $773 million. Such acquisitions demonstrate how heavily invested Merck is in immuno-oncology, an area in which it is currently well-positioned with the PD-1 inhibitor Keytruda. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 14, 2019 Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Source Type: news

Louisville physical therapy firm's buying binge brings it to Wisconsin
The Louisville-based physical and occupational therapy conglomerate continues its streak of acquisitions. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 14, 2019 Category: Pharmaceuticals Authors: Chris Larson Source Type: news